Home
Squadron Capital Management reported a 9.9% stake in NextCure NXTC · 271,127 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 9.9%
- Last report
- 6.5% · filed 25/10/24
- Shares held
- 271,127 sh
- Class
- Common Stock, $0.001 par value per share
- Stock
- NextCure NXTC
- Event date
- 25/12/31
- Filed
- 26/02/17
9.9% stake · +3.4pp from the last report
- Stake
- 9.9%
- Last report
- 6.5%
- Since last report
- +3.4pp
NextCure trades, last 26 weeks
What else happened in NextCure around then
Filed or reported within 30 days of the trade day · 25/12/01~01/30Squadron Capital Management's other 5% stake reports
- Squadron Capital Management
5% stakeTraws Pharma
5% stakeTraws Pharma
TRAW
0% stake
0 sh
0% stake
Filed 08/14
- Squadron Capital Management
5% stakeRelmada Therapeutics
5% stakeRelmada Therapeutics
RLMD
7% stake
7,350,000 sh
7% stake
Filed 08/14
- Squadron Capital Management
5% stakeNextCure
5% stakeNextCure
NXTC
1.6% stake
64,464 sh
1.6% stake
Filed 08/14
- Squadron Capital Management
5% stakeLipocine
5% stakeLipocine
LPCN
9.8% stake
810,000 sh
9.8% stake
Filed 08/14
- Squadron Capital Management
5% stakeC4 Therapeutics
5% stakeC4 Therapeutics
CCCC
6.9% stake
7,600,000 sh
6.9% stake
Filed 08/14
